Venu Holding Corp 8-K

What Happened

• Venu Holding Corp (VENU) announced it entered into an underwriting agreement with ThinkEquity LLC and closed a public offering on March 10, 2026 that generated approximately $80.1 million in net proceeds. The offering consisted of 14,340,000 shares of common stock and pre-funded warrants to purchase up to 4,410,000 shares, each issued together with common warrants (total accompanying common warrants up to 18,750,000).
• The offering pricing: $4.00 per share of common stock (with one common warrant) and $3.999 per pre‑funded warrant (with one common warrant). Each common warrant is exercisable immediately at $5.00 per share and expires five years after issuance. Each pre-funded warrant is exercisable immediately at $0.001 per share.

Key Details

• Underwriting: Agreement dated March 8, 2026 with ThinkEquity LLC as representative; closing occurred March 10, 2026. Net proceeds ≈ $80.1 million after fees and expenses.
• Over-allotment: The underwriters’ 45‑day over‑allotment option was exercised in full. On March 9 the representative purchased 2,812,500 common warrants at $0.0093 each; on March 10 the representative purchased 2,812,500 shares at $3.7107 per share.
• Representative compensation: The company issued the representative warrants to purchase up to 937,500 shares and, following the over‑allotment exercise, an additional warrant to purchase up to 140,625 shares. These representative warrants are exercisable immediately at $5.00 and expire in five years; aggregate purchase price for those warrants was $100.
• Use of proceeds: To fund development of The Sunset McKinney and The Sunset Broken Arrow, repay a $4.35 million promissory note related to a recently acquired Centennial, Colorado property (planned indoor music hall/restaurant), and for working capital and general corporate purposes.

Why It Matters

• The offering materially strengthens Venu’s cash position (≈$80.1M net), providing funding for specific development projects and near‑term obligations, which can reduce financing risk for those projects.
• Exercisable warrants and the issuance of pre‑funded warrants could lead to future share dilution if exercised; investors should note the exercise prices ($5.00 for common warrants; $0.001 for pre‑funded warrants) and the five‑year exercise window.
• Lock-ups: officers and directors agreed to a 90‑day lock-up from March 8, 2026, and the company agreed to a 60‑day restriction on certain offers/sales of equity, which limits near‑term insider share selling.